Oral sustained delivery of ambroxol from in situ-gelling pectin formulations

International Journal of Pharmaceutics

Volumn 271, Issue 1-2, 2004, Pages 233-240

  Kubo, Wataru ^a   Miyazaki, Shozo ^a   Dairaku, Masatake ^b   Togashi, Mitsuo ^b   Mikami, Ryozo ^b   Attwood, David ^c  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b Research Laboratory   (Japan)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Ambroxol; In situ gelation; Oral drug delivery; Pectin gels; Sustained release

Indexed keywords

ACID; AMBROXOL; BRAOMI; CALCIUM ION; DRUG VEHICLE; EXPECTORANT AGENT; PECTIN; SORBITOL;

AQUEOUS SOLUTION; ARTICLE; BIOAVAILABILITY; CONTROLLED RELEASE FORMULATION; DIFFUSION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FLOW KINETICS; GEL; GELATION; NONHUMAN; PRIORITY JOURNAL; STOMACH;

EID: 1142273421     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.11.027     Document Type: Article

References (14)

1. Alighieri T., Avanessian S., Berlini S., Bianchi S.G., Deluigi P., Valducci R., Guelen P.J.M. Bioavailability of ambroxol sustained release preparations. Part 1: dissolution studies. Arzneim-Forsch./Drug Res. 38:1988;92-94.
2. Botterblom M.H.A., Janssen T.J., Guelen P.J.M. Rapid and sensitive determination of ambroxol in human plasma and urine by high-performance liquid chromatography. J. Chromatogr. 421:1987;211-215.
3. Dumitriu, S., Vidal, P.F., Chornet, E., 1996. Hydrogels based on polysaccharides. In: Dumitriu, S. (Ed.) Polysaccharides in Medical Applications. Marcel Dekker, Inc., New York, pp. 125-242.
4. Heinanen M., Barbas C. Validation of an HPLC method for the quantification of ambroxol hydrochloride and benzoic acid in a syrup as pharmaceutical form stress test for stability evaluation. J. Pharm. Biomed. Anal. 24:2001;1005-1010.
5. Higuchi W.I. The analysis of data on the medicament release from ointments. J. Pharm. Sci. 51:1962;802-804.
6. Kubo W., Miyazaki S., Attwood D. Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations. Int. J. Pharm. 258:2003;55-64.
7. Miyazaki S., Aoyama H., Kawasaki N., Kubo W., Attwood D. In situ gelling gellan formulations as vehicles for oral delivery. J. Control. Release. 60:1999;287-295.
8. Miyazaki S., Kawasaki N., Kubo W., Endo K., Attwood D. Comparison of in situ gelling formulations for the oral delivery of cimetidine. Int. J. Pharm. 220:2001;161-168.
9. Miyazaki S., Kubo W., Attwood D. Oral sustained delivery of theophylline using in situ gelation of sodium alginate. J. Control. Release. 67:2000;275-280.
10. Miyazaki S., Nakamura T., Yokouchi C., Takada M. Effect of Pluronic gels on the rectal absorption of indomethacin in rabbits. Chem. Pharm. Bull. 32:1984;1243-1248.
11. Miyazaki S., Suisha F., Kawasaki N., Shirakawa M., Yamatoya K., Attwood D. Thermally reversible xyloglucan gels as vehicles for rectal drug delivery. J. Control. Release. 56:1998;75-83.
12. Vergin H., Bishop-Freundling G.B., Micka M., Nitsche V., Strobel K., Matzkies F. Untersuchungen zur pharmakokinetik und bioaquivalenz unterschiedlicher darreichungsformen von ambroxol. Arzneim-Forsch./Drug Res. 35:1985;1591-1595.
13. Watanabe A., Hanawa R., Sugihara M. Application of glyserogelatin as oral dosage form for the elderly. Yakuzaigaku. 54:1994;77-87.
14. Yamaoka K., Tanigawa Y., Nakagawa T., Uno T. Pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobiol. Dyn. 4:1981;879-885.